Related Experiment Video
Updated: Jan 17, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Return to work, after head and neck cancer: results from the French VICAN study
Purpose:
Returning to work after cancer is a major concern, particularly in the case of head and neck cancer (HNC). As the head and neck sphere is central to communication and appearance, it can be affected to varying degrees, which can be extremely disabling. Returning to work remains a challenge for this vulnerable population.
Methods:
Using univariate and multivariate logistic regression analyses including 153 HNC survivors, we studied how different sociodemographic and clinical factors were associated with non-return to work in the VICAN national epidemiological survey set up in France. Eligible participants were aged between 18 and 60.
Results:
After 5 years, 48.4% of survivors had still not returned to work. Factors associated with non-return to work were age over 50 (p < 0.001), cancer recurrence (p = 0.015), lack of high school diploma (p = 0.002), pain preventing return to work (p = 0.002), and lower physical quality of life score (p = 0.031). For those under 50, older age (p < 0.001), single status (p = 0.042), recurrence (p = 0.004), manual occupation (p = 0.043), no high school diploma (p = 0.010), pain (p < 0.001), depression (p = 0.039), and impaired physical score (p = 0.009) were significantly associated with not returning to work.
Conclusion:
Almost half of HNC survivors do not return to work following treatment. The return-to-work process is multifactorial and influenced by a wide range of medical, functional, and psychosocial variables. Our findings have identified specific patient-related risk factors, as well as key clinical and psychological determinants, which may facilitate the early identification of at-risk individuals and inform targeted interventions to optimize return-to-work outcomes.
Implications For Survivors:
The organization of a multidisciplinary post-treatment, "post-habilitation," cancer strategy seems increasingly inevitable, in order to plan a return to daily life (work, sociability, married life).
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...

